Xenon - Air Liquide

Drug Profile

Xenon - Air Liquide

Alternative Names: LENOXe

Latest Information Update: 08 Sep 2009

Price : $50

At a glance

  • Originator Air Liquide
  • Class Elements; General anaesthetics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Anaesthesia

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 31 Dec 2005 Preregistration for Anaesthesia in Europe (Inhalation)
  • 31 Oct 2005 Launched for Anaesthesia in Germany (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top